Furanoid sugar amino acids as dipeptide mimics in design of analogs of vasoactive intestinal peptide receptor binding inhibitor

Journal of Peptide Research

Volumn 66, Issue 2, 2005, Pages 75-84

  Prasad, S ^a   Mathur, A ^a   Jaggi, M ^a   Sharma, R ^a   Gupta, N ^a   Reddy, V R ^b   Sudhakar, G ^b   Kumar, S Uday ^b   Kumar, S Kiran ^b   Kunwar, A C ^b   Chakraborty, T K ^b  

^a DABUR RESEARCH FOUNDATION   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Anti cancer activity; Dipeptide isostere; Furanoid sugar amino acid; Peptidomimetics; Vasoactive intestinal peptide

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINO ACID DERIVATIVE; ANTINEOPLASTIC AGENT; DIPEPTIDE; FURAN DERIVATIVE; LEUCYLMETHIONYLTYROSYLPROLYLTHREONYLTYROSYLLEUCYLLYSINE; SUGAR AMINO ACID; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON TUMOR; CONTROLLED STUDY; DIASTEREOISOMER; DRUG DESIGN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE SYNTHESIS; TUMOR REGRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DIPEPTIDES; FURANS; HUMANS; MICE; MOLECULAR MIMICRY; PEPTIDE HYDROLASES; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; SERINE ENDOPEPTIDASES; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 22344442285     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.2005.00275.x     Document Type: Article

References (25)

1. v-selective RGD peptides. Angew. Chem. Int. Ed. 39, 2761-2763.
2. Hruby, V.J. & Balse, P.M. (2000) Conformational and topographical considerations in designing agonist peptidomimetics from pep tide leads. Clin. Med. Chem. 7, 945-970.
3. Chakraborty, T.K., Ghosh, S. & Jayaprakash, S. (2002) Sugar amino acids and their uses in designing bioactive molecules. Clin. Med. Chem. 9, 421-435.
4. Schweizer, F. (2002) Glycosamino acids: building blocks for combinatorial synthesis - implications for drug discovery. Angew. Chem. Int. Ed. Engl. 41, 231-253.
5. Gruner, S.A., Locardi, E., Lohof, E. & Kessler, H. (2002) Carbohydrate-based mimetics in drug design: sugar amino acids and carbohydrate scaffolds. Chem. Rev. 102, 491-514.
6. Chakraborty, T.K., Jayaprakash, S. & Ghosh, S. (2002) Sugar amino acid based scaffolds-novel peptidomimetics and their potential in combinatorial synthesis. Comb. Chem. High Throughput Screening 5, 373-387.
7. Graf von Roedern, E., Lohof, E., Hessler, G., Hoffmann, M. & Kessler, H. (1996) Synthesis and conformational analysis of linear and cyclic peptides containing sugar amino acids. J. Am. Chem. Soc. 118, 10156-10167.
8. Gruner, S.A., Keri, G., Schwab, R., Venetianer, A. & Kessler, H. (2001) Sugar amino acid containing somatostatin analogues that induce apoptosis in both drug sensitive and multi drug-resistant tumor cells. Org. Lett. 3, 3723-3725.
9. Chakraborty, T.K., Jayaprakash, S., Diwan, P.V., Nagaraj, R., Jampani, S.R.B. & Kunwar, A.C. (1998) Folded conformation in peptides containing furanoid sugar amino acids. J. Am. Chem. Soc. 120, 12962-12963.
10. Chakraborty, T.K., Srinivasu, P., Bikshapathy, E., Nagraj, R., Vairamani, M., Kumar, S.K. & Kunwar, A.C. (2003) Cyclic homooligomers of furanoid sugar amino acids. J. Org. Chem. 68, 6257-6263.
11. Grotenbreg, G.M., Timmer, M.S., Llamas-Saiz, A.L., Verdoes, M., van der Marel, G.A., van Raaij, M.J., Overkleeft, H.S. & Overhand, M. (2004) An unusual reverse turn structure adopted by a furanoid sugar amino acid incorporated in gramicidin S. J. Am. Chem. Soc. 126, 3444-3446.
12. El Oualid, F., Burm, B.E.A., Leroy, I. M., Cohen, L. H., van Boom, J.H., Overkleeft, H. S., van der Marel, G.A. & Overhand, M. (2004) Design, synthesis and evaluation of sugar amino acid based inhibitors of protein prenyl transferases PFT and PGGT-1. J. Med. Chem. 47, 3920-3923.
13. van Well, R.M., Overkleeft, H.S., van der Marel, G.A., Bruss, D., Thibault, G., de Groot, P.G., van Boom, J.H. & Overhand, M. (2003) Solid-phase synthesis of cyclic RGD-furanoid sugar amino peptides as integrin inhibitors. Bioorg. Med. Chem. Lett. 13, 331-334.
14. Singh, H., Kumar, A., Courtney, M., Townshed, J.R., Samad, Z. & Singh, P. (1988) A synthethic peptide, L-8-K, and its antibody both inhibit the specific binding of vasoactive intestinal peptide to hamster pancreatic cancer cells. Ann. NY Acad. Sci. 527, 679-681.
15. Mukherjee, R. & Jaggi, M. (1996) Drug for the treatment of Cancer. U.S. Patent. 6,156,725.
16. Burman, A.C., Prasad, S., Mukherjee, R., Jaggi, M., Singh, A.T. & Sharma, R. (2004) Peptides for the treatment of cancer. U. S. Patent 6,828,304.
17. Chakraborty, T.K., Tapadar, S. & Kumar, S.K. (2002) Cyclic trimer of 5-(aminomethyl)-2-furancarboxylic acid as a novel synthetic receptor for carboxylate recognition. Tetrahedron Lett. 43, 1317-1320.
18. Chakraborty, T.K., Reddy, V.R., Sudhakar, G., Kumar, U., Reddy, T.J., Kumar, S.K., Kunwar, A.C., Mathur, A., Sharma, R., Gupta, N. & Prasad, S. (2004) Conformational studies of 3,4-dideoxy furanoid sugar amino acid containing analogs of the receptor binding inhibitor of vasoactive intestinal peptide. Tetrahedron 60, 8329-8339.
19. Chakraborty, T.K., Ghosh, S., Jayaprakash, S., Sarma, J.A.R.P., Ravikanth, V., Diwan, P.V., Nagaraj, R. & Kunwar, A.C. (2000) Synthesis and conformational studies of peptidomimetics containing furanoid sugar amino acids and a sugar diacid. J. Org. Chem. 65, 6441-6457.
20. Atherton, E. & Sheppard, R.C. (1989) Solid Phase Peptide Synthesis: A Practical Appproach. IRL Press, Oxford, pp. 56-58.
21. Kaiser, E., Colescott, R.L., Bossinger, C.D. & Cook, P.I. (1970) Color test for the detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595-598.
22. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
23. Rekasi, Z., Varga, J.L., Schally, A.V., Halmos, G., Armatis, P., Groot, K. & Czompoly, T. (2000) Antagonists of Growth Hormone-Releasing Hormone and Vasoactive Intestinal Peptide Inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancers. Endocrinology 141, 2120-2128.
24. Levy, A., Gal, R., Granoth, R., Dreznik, Z., Fridkin, M. & Gozes, I. (2002) In vitro and in vivo treatment of colon cancer by VIP antagonists. Regul. Pept. 109, 8329-8339.
25. Reubi, J.C., Laderach, U., Waser, B., Gebbers, Jan, O., Robberecht, P. & Laissue, J.A. (2000) Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase Activating peptide receptor subtypes in human tumors and their tissues of origin. Can. Res. 60, 3105-3112.